An application of omega-3 polyunsaturated fatty acids in treatment of COPD patients with pulmonary hypertension and chronic cor pulmonale Source: Eur Respir J 2001; 18: Suppl. 33, 251s Year: 2001
Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids? Source: Eur Respir J 2001; 18: Suppl. 33, 199s Year: 2001
Effectiveness of omega-3 polyunsaturated fatty acids in combination with acetylsalicylic acid in patients with COPD, complicated by cor pulmonale and the syndrome of blood hypercoagulation Source: Eur Respir J 2004; 24: Suppl. 48, 59s Year: 2004
The role of free fatty acids in idiopathic pulmonary fibrosis Source: International Congress 2017 – From idiopathic pulmonary fibrosis (IPF) to rare diseases Year: 2017
Supplementation with polyunsaturated fatty acids influence the inflammatory response and airway nitric oxide in patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: novel aspects of airway function and inflammation Year: 2008
Intake of n -3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020 Year: 2021
Heart-type fatty acid-binding protein for risk assessment of chronic thromboembolic pulmonary hypertension Source: Eur Respir J 2008; 31: 1024-1029 Year: 2008
Omega-3 polyunsaturated fatty acids in correction of hemostasis system in patients with cor pulmonale Source: Eur Respir J 2002; 20: Suppl. 38, 100s Year: 2002
Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients Source: Eur Respir J 2007; 30: Suppl. 51, 145s Year: 2007
Short-chain fatty acids affect cystic fibrosis airway inflammation and bacterial growth Source: Eur Respir J 2015; 46: 1033-1045 Year: 2015
Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease Source: Eur Respir J, 49 (6) 1601923; 10.1183/13993003.01923-2016 Year: 2017
Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know? Year: 2007
Supplementation with n-3 fatty acids and markers of oxidative stress in elderly exposed to PM2.5 Source: Eur Respir J 2007; 30: Suppl. 51, 630s Year: 2007
Relationship between OSA and non-alcoholic fatty liver disease Source: ERS Conference Year: 2015
Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon? Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021 Year: 2021
Effect of omega-3 and phosphoethanolamine in patients with asthma Source: Annual Congress 2009 - Towards improving asthma control Year: 2009
Food and fatty acid intake and atopic disease in adults Source: Eur Respir J 2004; 23: 575-582 Year: 2004
Short-chain fatty acids are potent modulators of allergic airway inflammation Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation Year: 2012
Chronic intermittent hypoxia is a major trigger for non-alcoholic fatty liver disease Source: Annual Congress 2011 - Physiology and cardiometabolic comorbidities in obstructive sleep apnoea Year: 2011
The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy Source: Eur Respir J 2006; 28: Suppl. 50, 251s Year: 2006